Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese Volunteers
Status:
Completed
Trial end date:
2014-08-01
Target enrollment:
Participant gender:
Summary
The aim of the trial is to assess the relative bioavailability of fixed dose combination
tablets of Empagliflozin and metformin compared to the administration of single tablets
(Empagliflozin and metformin ) in Chinese subjects. The availability of a fixed dose
combination tablet is expected to significantly enhance patient's compliance with
antidiabetic treatment, in particular with concern to the frequent polypharmacy in diabetic
patients.